Long-Term Multilevel Intervention Impact on Human Papillomavirus Vaccination Rates Spanning the COVID-19 Pandemic.
J Low Genit Tract Dis
; 26(1): 13-19, 2022 Jan 01.
Article
in English
| MEDLINE | ID: covidwho-1592137
ABSTRACT
OBJECTIVE:
The aim of the study was to evaluate the long-term sustainability of a multilevel intervention and the COVID-19 pandemic impact on adolescent human papillomavirus (HPV) vaccination coverage. MATERIALS ANDMETHODS:
In 2016, a pediatric and family medicine practice within a federally qualified health center completed a multilevel intervention, Development of Systems and Education for Human Papillomavirus Vaccination. We examined the intervention impact on HPV vaccine initiation and completion rates among adolescents 10-18 years between March 2016 and October 2020. We determined the total number of HPV vaccine doses administered monthly. Data were plotted on statistical process control charts.RESULTS:
Vaccine initiation increased from an average of 14% to an average of 42% for 10-year-old patients and from an average of 72% to an average of 92% for 11- to 12-year-old patients between March 2016 and January 2017 and remained stable through March 2020. Complete vaccination by age 13 years increased from 62% to 88% through October 2020.CONCLUSIONS:
This intervention led to continued improvement for on-time HPV vaccination coverage 4 years after intervention completion.Clinical Trial Registration This trial has been registered at http//www.clinicaltrials.gov (identifier NCT02812732).
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Papillomavirus Infections
/
Alphapapillomavirus
/
Papillomavirus Vaccines
/
COVID-19
Type of study:
Experimental Studies
/
Observational study
/
Randomized controlled trials
Topics:
Long Covid
/
Vaccines
Limits:
Adolescent
/
Child
/
Humans
Language:
English
Journal:
J Low Genit Tract Dis
Journal subject:
Gynecology
Year:
2022
Document Type:
Article
Affiliation country:
Lgt.0000000000000648
Similar
MEDLINE
...
LILACS
LIS